Home/TCBalance Biopharmaceuticals/Prof. Dr. Olaf Weber

PD

Prof. Dr. Olaf Weber

CEO

TCBalance Biopharmaceuticals

Therapeutic Areas

Autoimmune Diseases Transplant Rejection Graft-versus-host Disease Hyperinflammation

TCBalance Biopharmaceuticals Pipeline

Drug	Indication	Phase
Treg Cell Therapy Platform	Autoimmune diseases, Transplant rejection, GvHD, Hyperinflammation	Pre-clinical

Leadership Team at TCBalance Biopharmaceuticals

Prof. Dr. Hans-Dieter Volk

Prof. Dr. Petra Reinke

CMO & Head of Clinical Development & Cell Therapy Manufacturing

Dr. Dimitrios L. Wagner

Head of Research & Preclinical Development

View full TCBalance Biopharmaceuticals profile